Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Cannabidiol,Tetrahydrocannabinol
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved FDF
Sponsor : MediPharm Labs
Deal Size : Undisclosed
Deal Type : Agreement
Canntab and Medipharm Labs Enter Into a Wholesale Tablet Purchase Agreement
Details : The agreement will be composed of a mix of Canntab's proprietary instant release tablets delivering THC, CBD and a combination of Cannabidiol/Tetrahydrocannabinol, in 12 different strengths. MediPharm will purchase and distribute cannabis products across...
Product Name : Cannabidiol/Tetrahydrocannabinol-Generic
Product Type : Controlled Substance
Upfront Cash : Undisclosed
February 06, 2020
Lead Product(s) : Cannabidiol,Tetrahydrocannabinol
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Sponsor : MediPharm Labs
Deal Size : Undisclosed
Deal Type : Agreement